Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits 
Zelenskiy Awaits U.S. Response After Russian Strikes Damage Ukraine’s Energy Infrastructure 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Illinois Joins WHO Global Outbreak Network After U.S. Exit, Following California’s Lead 
UN Warns of Growing Nuclear Risks as New START Treaty Expires 
U.S.-Iran Nuclear Talks Expected in Oman Following Venue Change Request 
Trump Plans Call With Savannah Guthrie After Mother’s Disappearance, Federal Support Considered 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Trump Calls for “Nationalizing” Voting, Drawing Backlash Over Election Authority 
Trump Endorses Clay Fuller in Georgia Special Election to Replace Marjorie Taylor Greene 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Russia Prepares for Post–New START Era as U.S.-Russia Nuclear Arms Control Nears Collapse 
Trump, Petro Discuss Sanctions and Strengthening U.S.–Colombia Relations After Oval Office Meeting 
The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.
